Merck Rallies Of Drug Trial Results

Loading...
Loading...

Merck & Co., Inc. MRK shares are trading higher by $1.09 at $57.03 in Thursday's session. The catalyst for the rally is the announcement that Keytruda has met primary and secondary endpoints.

After a higher open, it retreated and found support just above Wednesday's close ($56.09) at $56.13 and began to move higher. So far, it has reached $57.31 and isn't far off that level.

That marks the highest level for the issue since early May, when it put in a pair of highs at the $57.80 area.

Posted In: TechnicalsIntraday UpdateMoversTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...